(A–B) Ten- to twelve-week-old BALB/c mice, either wild-type (WT) or deficient in C3aR (C3aR−/−) or C5aR (C5aR−/−), were orally inoculated with P. gingivalis (Pg) or vehicle only (Sham) and assessed for bone loss (A) and levels of oral anaerobic bacteria (B). (C) Quantitative detection, by real-time PCR of the ISPg1 gene, of wild-type Pg or a gingipain-deficient isogenic mutant (KDP128) in the periodontal tissue of inoculated WT BALB/c mice. ND, not detected. (D) WT, C3aR−/−, or C5aR−/− mice were orally inoculated with Pg or KDP128 and assessed for levels of oral anaerobic bacteria seven days later. (E–F) WT mice were inoculated with Pg or KDP128 and euthanized six weeks post-inoculation: Gingiva were dissected and processed for quantitative real-time PCR to determine gingival mRNA expression of the indicated molecules (normalized against GAPDH mRNA levels and presented as fold change relative to sham mice) (E), whereas defleshed maxillae were assessed for periodontal bone loss (F). (G) Effects of C5aR antagonist (C5aRA), or inactive analog control (iC5aRA ctrl), on the numbers of P. gingivalis or total bacteria in the periodontal tissue of mice with or without previous inoculation with P. gingivalis (for details see Experimental Procedures). ND, Pg not detected. (H) Periodontal bone levels in C3aR−/− and C5aR−/− mice relative to WT SPF or GF mice. Data are means ± SD (A, n = 9; C, E, F, and G, n = 5; H, n = 8 mice per group). In A, F, and H, negative values indicate bone loss relative to bone levels of the indicated controls (zero baseline), whereas positive values indicate increased bone levels. CFU counts are shown for each individual mouse with horizontal lines denoting mean values. *p <0.05; **p <0.01 versus corresponding control.